Overview of treatment plan quality in a high dose rate prostate brachytherapy workflow

被引:0
|
作者
Panetta, J. V. [1 ]
Veltchev, I. [1 ]
Horwitz, E. [1 ]
Hallman, M. [1 ]
Wong, K. [1 ]
Price, R. A. [1 ]
Ma, C. M. C. [1 ]
机构
[1] Fox Chase Canc Ctr, Dept Radiat Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA
关键词
modality combinations: Varian Varisource/US; Elekta microSelectron/CT; ULTRASOUND; MONOTHERAPY; CANCER; CT; DOSIMETRY; PROGRAM;
D O I
10.1016/j.brachy.2024.08.255
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: High dose rate brachytherapy (HDR-BT) has been shown to be an effective treatment for prostate cancer, with treatment plan quality dependent on a number of factors. In this work, we report on the overall performance of our ultrasound (US)-based workflow and the impact of several treatment-specific variables. METHODS AND MATERIALS: Patients who underwent HDR-BT (boost, monotherapy, and retreatment) using Varian Bravos/US from 2021 to 2023 were sampled for this study. Treatment plan quality was analyzed and plans were categorized with regard to a number of metrics, including: prostate volume, treating physician, planning physicist, number of needles included, estimated planning time, rectum-prostate separation, and bladder-prostate separation. The performance of this program was compared to the performance of our program using previously used RESULTS: Plan quality for our Bravos/US workflow was shown to be consistently above acceptability criteria for all personnel involved; on average: prostate V100%: 98.9% f 0.1%, rectum V75%: 0.04 f 0.01 cc, bladder V75%: 0.06 f 0.01cc, urethra V125%: 0.00 f 0.00 cc. Prostate coverage was statistically improved with this workflow compared to that using our previous modalities. There was a statistical correlation between organ-at-risk sparing/prostate coverage ratio and prostate volume, number of needles/prostate volume, bladder-prostate separation, and rectum-prostate separation. There was no correlation between plan quality and planning time. CONCLUSIONS: Our US-based HDR-BT program led to target coverage and organ-at-risk sparing that exceeded department thresholds. Results were acceptable regardless of the personnel involved and improved plan quality was obtained using more needles/prostate volume and increased spacing between the prostate and the rectum and bladder. (c) 2024 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:698 / 704
页数:7
相关论文
共 50 条
  • [11] Sensitivity of dose-volume indices to computation settings in high-dose-rate prostate brachytherapy treatment plan evaluation
    van der Meer, Marjolein C.
    Bosman, Peter A. N.
    Pieters, Bradley R.
    Niatsetski, Yury
    van Wieringen, Niek
    Alderliesten, Tanja
    Bel, Arjan
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2019, 20 (04): : 66 - 74
  • [12] High dose rate brachytherapy as a boost for the treatment of localized prostate cancer
    Phan, Thinh P.
    Syed, A. M. Nisar
    Puthawala, Ajmel
    Sharma, Anil
    Khan, Farhan
    JOURNAL OF UROLOGY, 2007, 177 (01): : 123 - 127
  • [13] High dose rate brachytherapy for prostate cancer
    Hoskin, P.
    CANCER RADIOTHERAPIE, 2008, 12 (6-7): : 512 - 514
  • [14] To plan or not to plan: Multiple high dose rate (HDR) brachytherapy insertions
    Lowenstein, JR
    Roll, J
    Ibbott, GS
    MEDICAL PHYSICS, 2003, 30 (06) : 1464 - 1464
  • [15] High-Dose-Rate Prostate Brachytherapy Consistently Results in High Quality Dosimetry
    White, Evan C.
    Kamrava, Mitchell R.
    Demarco, John
    Park, Sang-June
    Wang, Pin-Chieh
    Kayode, Oluwatosin
    Steinberg, Michael L.
    Demanes, D. Jeffrey
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (02): : 543 - 548
  • [16] An Automated Treatment Plan Quality Assurance Program for High-Dose Rate (HDR) Brachytherapy with a VaginalCylinder Applicator
    Zhou, Y.
    Tan, J.
    Jiang, S.
    Albuquerque, K.
    Jia, X.
    MEDICAL PHYSICS, 2016, 43 (06) : 3622 - 3623
  • [17] Automated Plan Verification Software for Ultrasound-Planned High Dose Rate Prostate Brachytherapy
    HarriS, T.
    Molodowitch, C.
    Sugar, E.
    O'Farrell, D.
    King, M.
    Buzurovic, I.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S1095 - S1095
  • [18] Dosimetric and workflow impact of synthetic-MRI use in prostate high-dose-rate brachytherapy
    Podgorsak, Alexander R.
    Venkatesulu, Bhanu P.
    Abuhamad, Mohammad
    Harkenrider, Matthew M.
    Solanki, Abhishek A.
    Roeske, John C.
    Kang, Hyejoo
    BRACHYTHERAPY, 2023, 22 (05) : 686 - 696
  • [19] High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer
    Hoskin, PJ
    RADIOTHERAPY AND ONCOLOGY, 2000, 57 (03) : 285 - 288
  • [20] Advantages of High-Dose Rate (HDR) Brachytherapy in Treatment of Prostate Cancer
    Molokov, A. A.
    Vanina, E. A.
    Tseluyko, S. S.
    PHYSICS OF CANCER: INTERDISCIPLINARY PROBLEMS AND CLINICAL APPLICATIONS (PC IPCA), 2017, 1882